In the latter, the insulin-like growth factor receptor (IGFR)-IRS1 pathway, as a key upstream signal, mediates PI3K activation in a SHP2-independent manner, leading to acquired resistance to sotorasib or ARS-1620 in NSCLC cells (Fig. 6c) [199]. Here, PIK3CA is linked to non-small cell lung carcinoma.